Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Folia Biologica|January 5, 2001
BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phaseB Schultheis, G Pasternak, R HehlmannJournal of Cancer Research and Clinical Oncology|January 8, 1999
Chronic myelogenous leukemia: molecular and cellular aspectsG Pasternak, A Hochhaus, B Schultheis, et al.Folia Biologica|January 5, 2001
Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term cultureB Schultheis, B Heissig, G Pasternak, et al.Gene Therapy|December 17, 2004
Stable RNA interference (RNAi) as an option for anti-bcr-abl therapyM Scherr, K Battmer, B Schultheis, et al.Cytopathology : Official Journal of the British Society for Clinical Cytology|June 19, 2007
Diagnostic accuracy of cytology and immunocytology in carcinomatous effusionsG Metzgeroth, C Kuhn, B Schultheis, et al.Infection and Immunity|May 1, 1993
Cytocidal effects of Escherichia coli hemolysin on human T lymphocytesD Jonas, B Schultheis, C Klas, et al.Leukemia|May 8, 1999
Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?G Pasternak, B Schultheis, B Heissig, et al.Leukemia|December 22, 1999
Analysis of p73 and p53 gene deletions in multiple myelomaB Schultheis, A Krämer, A Willer, et al.Annals of Hematology|March 10, 2001
Predominantly BCR-ABL negative myeloid precursors in interferon-alpha treated chronic myelogenous leukemia: a follow-up study of peripheral blood colony-forming cells with fluorescence in situ hybridizationC Sick, B Schultheis, G Pasternak, et al.Cancer Chemotherapy and Pharmacology|July 8, 2011
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumorsB Schultheis, G Kummer, M Zeth, et al.Pageof 3